FdaNdcDirectoryPulse / compare
BRYTLY vs Magnilife Leg and Back Pain Relief: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and Magnilife Leg and Back Pain Relief (2026-09-25) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to Magnilife Leg and Back Pain Relief?
| Field | BRYTLY | Magnilife Leg and Back Pain Relief |
|---|---|---|
| Product | BRYTLY | Magnilife Leg and Back Pain Relief |
| Generic name | Apraclonidine Hydrochloride | ATROPA BELLADONNA, CAPSICUM, HYPERICUM PERFORATUM WHOLE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE |
| NDC | 0065-8596 | 43689-0067 |
| Labeler | Alcon Laboratories, Inc. | The Magni Group, Inc. dba Magnilife |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | UNAPPROVED HOMEOPATHIC |
| Application number | NDA220341 | |
| Dosage form | SOLUTION/ DROPS | CREAM |
| Route | OPHTHALMIC | TOPICAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | ATROPA BELLADONNA 3 [hp_X]/113g; CAPSICUM 3 [hp_X]/113g; HYPERICUM PERFORATUM WHOLE 3 [hp_X]/113g; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/113g; TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/113g |
| Marketing start | 2026-10-16 | 2026-09-25 |
| Package configurations | 3 | 3 |
| Launch Signal Score | 45/100 | 15/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · Magnilife Leg and Back Pain Relief
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.